Citius Pharmaceuticals (CTXR) Total Debt (2011 - 2026)
Citius Pharmaceuticals' (CTXR) quarterly Total Debt came in at $6.4 million in Q2 2026, up 541.02% on a YoY basis from $1000000.0 in Q2 2025, and up 541.02% quarter-over-quarter from $1.0 million in Q4 2025.
Powered by 
Analysis
Citius Pharmaceuticals (CTXR) Total Debt (2011 - 2026) Analysis & Trends
Citius Pharmaceuticals (CTXR) has reported Total Debt for 13 consecutive years, with $6.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Debt rose 541.02% year-over-year to $6.4 million; the trailing twelve-month figure through Jun 2026 stood at $6.4 million (up 541.02% YoY), and the FY2025 full-year result was $1.0 million, changed N/A from the prior year.
- Total Debt improved to $6.4 million in Q2 2026 per CTXR's latest filing, from $1.0 million in the prior quarter.
- Across five years, Total Debt topped out at $6.4 million in Q2 2026 and bottomed at $1.0 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.22 Bn | 620.47 Bn | 17.26 Bn | 60.73 Bn |
| 2 | AbbVie | 446.28 Bn | 439.71 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 357.56 Bn | 350.42 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 268.11 Bn | 260.42 Bn | 11.24 Bn | 9.59 Bn |
| 5 | Pfizer | 156.86 Bn | 145.17 Bn | 10.94 Bn | 63.19 Bn |
| 6 | Sanofi | 52.10 Bn | 44.72 Bn | 10.79 Bn | 25.19 Bn |
| 7 | Revolution Medicines | 43.01 Bn | 43.01 Bn | - | - |
| 8 | Incyte | 24.82 Bn | 20.28 Bn | 1.57 Bn | 38.81 Mn |
| 9 | United Therapeutics | 21.39 Bn | 18.73 Bn | 683.80 Mn | - |
| 10 | Citius Pharmaceuticals | 15.27 Mn | 15.27 Mn | 1.00 Mn | 6.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.41 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Jun 30, 2021 | 172,970.00 |
| Mar 31, 2021 | 337,553.00 |
| Dec 31, 2020 | 337,553.00 |
| Sep 30, 2020 | 337,553.00 |
| Jun 30, 2020 | 337,553.00 |
| Mar 31, 2020 | 172,970.00 |
| Dec 31, 2019 | 172,970.00 |
| Sep 30, 2019 | 172,970.00 |
| Jun 30, 2019 | 172,970.00 |
| Mar 31, 2019 | 172,970.00 |
| Dec 31, 2018 | 172,970.00 |
| Sep 30, 2018 | 172,970.00 |
| Jun 30, 2018 | 172,970.00 |
| Mar 31, 2018 | 172,970.00 |
| Dec 31, 2017 | 172,970.00 |
| Sep 30, 2017 | 172,970.00 |